Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07113353 · ClinicalTrials.gov registry record
Non-Invasive ICP Monitoring Study
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 30
- Enrollment target
NCT07113353: Recruiting study, sponsored by University of Texas Southwestern Medical Center.
NCT07113353 is a clinical trial that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07113353 is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
Measuring the pressure inside the skull, which is called intracranial pressure, is important to treat severe neurological illness. Currently, measuring intracranial pressure requires doctors to place an invasive pressure monitor. Recently, a non-invasive intracranial pressure monitor has been developed. This monitor has a tiny pin that is placed on the head which measures the tiny movements of the skull every time the heart beats. This produces a waveform that looks very similar to an invasive intracranial pressure waveform. However, we don't know enough about how the non-invasive device to make it clinically useful yet.
Interventions
- DEVICE Brain4Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-04-10 |
| Est. Completion | 2027-10-01 |
What NCT07113353 shows while recruiting
NCT07113353 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Brain4Care is the first listed.
NCT07113353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07113353 about?
NCT07113353 is a clinical study titled "Non-Invasive ICP Monitoring Study". Measuring the pressure inside the skull, which is called intracranial pressure, is important to treat severe neurological illness. Currently, measuring intracranial pressure requires doctors to place an invasive pressure monitor. Recently, a non-invasive intracranial pressure monitor has been develo...
What is the current status of trial NCT07113353?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2026-04-10. Estimated completion is 2027-10-01.
What interventions are being tested in trial NCT07113353?
The interventions under investigation include: Brain4Care (DEVICE).
Who is sponsoring clinical trial NCT07113353?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI